Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study.
Hamroun A, Frimat L, Laville M, Metzger M, Combe C, Fouque D, Jacquelinet C, Ayav C, Liabeuf S, Lange C, Herpe YE, Zee J, Glowacki F, Massy ZA, Robinson B, Stengel B; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) study group. Hamroun A, et al. Nephrol Dial Transplant. 2022 Aug 22;37(9):1700-1709. doi: 10.1093/ndt/gfab249. Nephrol Dial Transplant. 2022. PMID: 34473306
BACKGROUND: Acute-on-chronic kidney disease (ACKD) is poorly understood and often overlooked. ...Within 1 year, only 63% of the patients had recovered their previous kidney function, 13.7% had started kidney replacement therapy and 12.7% had died. ...
BACKGROUND: Acute-on-chronic kidney disease (ACKD) is poorly understood and often overlooked. ...Within 1 year, only 63% of th …
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
El Chamieh C, Larabi IA, Laville SM, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Pecoits-Filho R, Lange C, Stengel B, Alencar De Pinho N, Alvarez JC, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. El Chamieh C, et al. Toxins (Basel). 2023 Apr 7;15(4):276. doi: 10.3390/toxins15040276. Toxins (Basel). 2023. PMID: 37104214 Free PMC article.
Use of proton-pump inhibitors (PPIs) is common in patients with chronic kidney disease (CKD). PPIs and many uremic toxins (UTs) are eliminated by the kidney's tubular organic anion transporter system. ...
Use of proton-pump inhibitors (PPIs) is common in patients with chronic kidney disease (CKD). PPIs and many uremic toxins (UTs …
Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S, Lambert O, Metzger M, Hamroun A, Laville M, Laville SM, Frimat L, Pecoits-Filho R, Fouque D, Massy ZA, Jacquelinet C, Stengel B; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD REIN) Study Group. Liabeuf S, et al. Br J Clin Pharmacol. 2021 Jul;87(7):2967-2976. doi: 10.1111/bcp.14713. Epub 2021 Jan 19. Br J Clin Pharmacol. 2021. PMID: 33368448 Free article.
AIMS: Long-term use of proton pump inhibitors (PPIs) has been associated with adverse kidney events in the general population, but their impact among chronic kidney disease (CKD) patients is unclear. ...Our results call attention to its potential risks of bot …
AIMS: Long-term use of proton pump inhibitors (PPIs) has been associated with adverse kidney events in the general population, but th …
Adverse Drug Reactions in Patients with CKD.
Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Stengel B, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Laville SM, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1090-1102. doi: 10.2215/CJN.01030120. Epub 2020 Jul 1. Clin J Am Soc Nephrol. 2020. PMID: 32611662 Free PMC article.
We estimated the incidence of overall and serious adverse drug reactions and assessed the probability of causation, preventability, and factors associated with adverse drug reactions in patients seen by nephrologists. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Chro …
We estimated the incidence of overall and serious adverse drug reactions and assessed the probability of causation, preventability, and fact …
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
El Chamieh C, Larabi IA, Alencar De Pinho N, Lambert O, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Laville S, Lange C, Alvarez JC, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. El Chamieh C, et al. Clin Kidney J. 2023 Sep 28;17(1):sfad248. doi: 10.1093/ckj/sfad248. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186868 Free PMC article.
BACKGROUND: Kynurenine is a protein-bound uremic toxin. Its circulating levels are increased in chronic kidney disease (CKD). Experimental studies showed that it exerted deleterious cardiovascular effects. ...
BACKGROUND: Kynurenine is a protein-bound uremic toxin. Its circulating levels are increased in chronic kidney disease (CKD). …
Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results.
Cheddani L, Liabeuf S, Essig M, Snanoudj R, Jacquelinet C, Kerleau C, Metzger M, Balkau B, Drüeke TB, Hourmant M, Massy ZA; Nantes Kidney and Pancreas Transplantation Group and the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Cheddani L, et al. Nephrol Dial Transplant. 2021 Jan 1;36(1):176-184. doi: 10.1093/ndt/gfaa026. Nephrol Dial Transplant. 2021. PMID: 32162656
The objective of the present study was to assess and compare the risk of mortality and frequency of non-lethal cardiovascular (CV) events in kidney transplant recipients (KTRs) beyond 1 year after successful transplantation versus patients with chronic kidney …
The objective of the present study was to assess and compare the risk of mortality and frequency of non-lethal cardiovascular (CV) events in …